By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies today filed documents with the US Securities and Exchange Commission registering 2,370,586 shares of common stock that may be sold from time to time by shareholders.

The shares were issued to the selling stockholders as part of Life Technologies' acquisition of BioTrove in November 2009.They received the shares as part of private placements in December and January.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.